(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 2.73% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 3.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.08%.
Mckesson's revenue in 2023 is $273,903,000,000.On average, 4 Wall Street analysts forecast MCK's revenue for 2023 to be $37,595,210,341,320, with the lowest MCK revenue forecast at $36,633,845,067,813, and the highest MCK revenue forecast at $38,494,468,471,692. On average, 4 Wall Street analysts forecast MCK's revenue for 2024 to be $39,533,443,915,162, with the lowest MCK revenue forecast at $37,718,266,806,426, and the highest MCK revenue forecast at $41,741,149,649,497.
In 2025, MCK is forecast to generate $41,707,150,925,974 in revenue, with the lowest revenue forecast at $41,707,150,925,974 and the highest revenue forecast at $41,707,150,925,974.